BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12454529)

  • 1. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.
    Olive DL
    Obstet Gynecol Surv; 2002 Nov; 57(11 Suppl 4):S55-63. PubMed ID: 12454529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective progesterone receptor modulators and their therapeutical use].
    Driák D; Sehnal B; Svandová I
    Ceska Gynekol; 2013 Apr; 78(2):175-81. PubMed ID: 23710982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective progesterone receptor modulators: new possibilities for gynecologic hormone therapy.
    Sarvilinna N; Unkila-Kallio L; Härkki P; Tiitinen A; Heikinheimo O
    Duodecim; 2017; 133(1):27-33. PubMed ID: 29199806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
    Bouchard P; Chabbert-Buffet N; Fauser BC
    Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor modulators and progesterone antagonists in women's health.
    Spitz IM; Chwalisz K
    Steroids; 2000; 65(10-11):807-15. PubMed ID: 11108892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immninent dawn of SPRMs in obstetrics and gynecology.
    Chabbert-Buffet N; Pintiaux A; Bouchard P
    Mol Cell Endocrinol; 2012 Jul; 358(2):232-43. PubMed ID: 22415029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective progesterone receptor modulators: future clinical applications].
    Bouchard P; Ouzounian S; Chabbert-Buffet N
    Bull Acad Natl Med; 2008; 192(6):1159-71; discussion 1172-3. PubMed ID: 19235480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies.
    Wagenfeld A; Saunders PT; Whitaker L; Critchley HO
    Expert Opin Ther Targets; 2016 Sep; 20(9):1045-54. PubMed ID: 27138351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.
    Islam MS; Afrin S; Jones SI; Segars J
    Endocr Rev; 2020 Oct; 41(5):. PubMed ID: 32365199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective progesterone receptor modulators: current applications and perspectives.
    Chabbert-Buffet N; Kolanska K; Daraï E; Bouchard P
    Climacteric; 2018 Aug; 21(4):375-379. PubMed ID: 29338440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs).
    Spitz IM
    Semin Reprod Med; 2005 Feb; 23(1):3-7. PubMed ID: 15714385
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis.
    Chwalisz K; Garg R; Brenner RM; Schubert G; Elger W
    Ann N Y Acad Sci; 2002 Mar; 955():373-88; discussion 389-93, 396-406. PubMed ID: 11949964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone antagonists and progesterone receptor modulators.
    Spitz IM
    Expert Opin Investig Drugs; 2003 Oct; 12(10):1693-707. PubMed ID: 14519088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases.
    Islam MS; Chen LW; Segars JH
    Clin Obstet Gynecol; 2021 Dec; 64(4):813-836. PubMed ID: 34524172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
    Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
    Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.
    Chabbert-Buffet N; Meduri G; Bouchard P; Spitz IM
    Hum Reprod Update; 2005; 11(3):293-307. PubMed ID: 15790602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies.
    Critchley HOD; Chodankar RR
    J Mol Endocrinol; 2020 Jul; 65(1):T15-T33. PubMed ID: 32599565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.